Pfizer : PFE

All Pfizer Articles

1469 Articles

Paul Ausick | Jul 28, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Tuesday

thinkstockJuly 28, 2015: Markets opened higher on Tuesday after the Shanghai market closed with a modest loss compared with Monday’s…

Paul Ausick | Jul 28, 2015 at 7:42 AM EDT

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

ThinkstockPfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted…

Paul Ausick | Jul 27, 2015 at 2:17 PM EDT

What to Look For in Pfizer Earnings

Wikimedia CommonsBefore the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

Paul Ausick | Jul 9, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the DJIA on Thursday

thinkstockJuly 9, 2015: Markets opened higher on Thursday and that’s when the major indexes posted their daily highs. New claims…

Lee Jackson | Jul 8, 2015 at 8:55 AM EDT

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay…

Paul Ausick | Jul 7, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow on Tuesday

thinkstockJuly 7, 2015: Markets opened slightly higher on Tuesday but a reversal took just moments to set in and U.S.…

Chris Lange | Jun 26, 2015 at 11:35 AM EDT

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?

Chris Lange | Jun 25, 2015 at 8:10 AM EDT

Short Sellers Become More Focused on Big Pharma

The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Chris Lange | Jun 10, 2015 at 8:30 AM EDT

Short Sellers Back Off Big Pharma

The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Jon C. Ogg | Jun 7, 2015 at 9:40 AM EDT

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more…

1 … 57 58 59 60 61 … 98

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Lifted the Dow on Tuesday

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

What to Look For in Pfizer Earnings

Short Sellers Run For Cover From Major Pharma

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

The 4 Stocks That Boosted the DJIA on Thursday

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

The 4 Stocks That Boosted the Dow on Tuesday

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

What Happens to Nvidia If Jensen Huang Steps Down?

XRP Price Prediction After the White House’s July 4 CLARITY Act Deadline

Jeffrey Gundlach’s Debt Restructure Trade: 2 Stocks and 2 ETFs Built for the Storm

3 Higher-Yield Alternatives to a Traditional Savings Account

How Corporate Executives With $5 Million 401(k)s Avoid the Top Tax Bracket in Retirement

What Happens to Nvidia If Jensen Huang Steps Down?

XRP Price Prediction After the White House’s July 4 CLARITY Act Deadline

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Lifted the Dow on Tuesday

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

What to Look For in Pfizer Earnings

Short Sellers Run For Cover From Major Pharma

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

The 4 Stocks That Boosted the DJIA on Thursday

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

The 4 Stocks That Boosted the Dow on Tuesday

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

What Happens to Nvidia If Jensen Huang Steps Down?

XRP Price Prediction After the White House’s July 4 CLARITY Act Deadline

Jeffrey Gundlach’s Debt Restructure Trade: 2 Stocks and 2 ETFs Built for the Storm

Featured Reads

3 Higher-Yield Alternatives to a Traditional Savings Account

How Corporate Executives With $5 Million 401(k)s Avoid the Top Tax Bracket in Retirement